Increased levels of lysosomal cysteinyl cathepsins in human varicose veins: A histology study

Summary

Varicose veins are a major chronic venous disease characterised by extensive remodelling of the extracellular matrix architecture in the vascular wall. Although matrix metalloproteinases have been implicated in these pathologic events, little is known about the functional relevance of other protease family members. Here, we studied the distribution of lysosomal cysteine proteases, cathepsins B, L, K, and S, and their endogenous inhibitor, cystatin C, in long saphenous vein specimens from nine normal donors and 18 patients with varicose veins (VVs). Immunohistochemical analysis demonstrated increased levels of cathepsins L, K, B, and S and reduced levels of cystatin C in VVs. This imbalance between cysteinyl cathepsins and cystatin C may favour VV remodelling. To investigate the inflammatory mechanism of their expression, we examined a detailed inflammatory cell profile in VVs, including macrophages, T lymphocytes, and mast cells. Increased numbers of CD3-positive T cells and tryptase-positive mast cells were found in VVs, and enhanced levels of cysteinyl cathepsins were detected from lesion CD3-positive T cells, chymase-positive mast cells, endothelial cells, and smooth-muscle cells. Elevated cathepsins, and their co-localisation to infiltrated inflammatory cells and to vascular cells, suggest that these proteases participate in extracellular matrix degradation in response to inflammation during VV pathogenesis.

Keywords

Cysteinyl cathepsin - cystatin C - varicose vein - inflammatory cell - vascular cell

• References

• 1 Meissner MH, Gloviczki P, Bergan J. et al. Primary chronic venous disorders.. J Vasc Surg 2007; 46 Suppl S 54S-67S.
• 2 Badier-Commander C, Couvelard A, Henin D. et al. Smooth muscle cell modulation and cytokine overproduction in varicose veins.. An in situ study. J Pathol 2001; 193: 398-407.
• 3 Gandhi RH, Irizarry E, Nackman GB. et al. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins.. J Vasc Surg 1993; 18: 814-820.
• 4 Sansilvestri-Morel P, Rupin A, Jullien ND. et al. Decreased production of collagen type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: Possible implication of MMP-3.. J Vasc Res 2005; 42: 388-398.
• 5 Raffetto JD, Khalil RA. Matrix metalloproteinases in venous tissue remodelling and varicose vein formation.. Curr Vasc Pharmacol 2008; 6: 158-172.
• 6 Sansilvestri-Morel P, Fioretti F, Rupin A. et al. Comparison of extracellular matrix in skin and saphenous veins from patients with varicose veins: Does the skin reflect venous matrix changes?. Clin Sci 2007; 112: 229-239.
• 7 Ishikawa Y, Asuwa N, Ishii T. et al. Collagen alteration in vascular remodelling by hemodynamic factors.. Virchows Arch 2000; 437: 138-148.
• 8 Kowalewski R, Sobolewski K, Wolanska M. et al. Matrix metalloproteinases in the vein wall.. Int Angiol 2004; 23: 164-169.
• 9 Woodside KJ, Hu M, Burke A. et al. Morphologic characteristics of varicose veins: Possible role of metalloproteinases.. J Vasc Surg 2003; 38: 162-169.
• 10 Aravind B, Saunders B, Navin T. et al. Inhibitory effect of TIMP influences the morphology of varicose veins.. Eur J Vasc Endovasc Surg 2010; 40: 754-765.
• 11 Liu J, Sukhova GK, Sun JS. et al. Lysosomal cysteine proteases in atherosclerosis.. Arterioscler Thromb Vasc Biol 2004; 24: 1359-1366.
• 12 Garcia-Touchard A, Henry TD, Sangiorgi G. et al. Extracellular proteases in atherosclerosis and restenosis.. Arterioscler Thromb Vasc Biol 2005; 25: 1119-1127.
• 13 Lutgens SP, Cleutjens KB, Daemen MJ. et al. Cathepsin cysteine proteases in cardiovascular disease.. FASEB J 2007; 21: 3029-3041.
• 14 Cheng XW, Huang Z, Kuzuya M. et al. Cysteine protease cathepsins in atherosclerosis-based vascular disease and its complications.. Hypertension 2011; 58: 978-986.
• 15 Aikawa E, Aikawa M, Libby P. et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.. Circulation 2009; 119: 1785-1794.
• 16 Sukhova GK, Zhang Y, Pan JH. et al. Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice.. J Clin Invest 2003; 111: 897-906.
• 17 Kitamoto S, Sukhova GK, Sun J. et al. Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice.. Circulation 2007; 115: 2065-2075.
• 18 Liu J, Sukhova GK, Yang JT. et al. Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells.. Atherosclerosis 2006; 184: 302-311.
• 19 Jaffer FA, Kim DE, Quinti L. et al. Optical visualisation of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor.. Circulation 2007; 115: 2292-2298.
• 20 Platt MO, Ankeny RF, Shi GP. et al. Expression of cathepsin K is regulated by shear stress in cultured endothelial cells and is increased in endothelium in human atherosclerosis.. Am J Physiol Heart Circ Physiol 2007; 292: H1479-1486.
• 21 Shi GP, Sukhova GK, Grubb A. et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms.. J Clin Invest 1999; 104: 1191-1197.
• 22 Liu J, Divoux A, Sun J. et al. Genetic deficiency and pharmacological stabilisation of mast cells reduce diet-induced obesity and diabetes in mice.. Nat Med 2009; 15: 940-945.
• 23 Libby P, Lee RT. Matrix matters.. Circulation 2000; 102: 1874-1876.
• 24 Libby P, Shi GP. Mast cells as mediators and modulators of atherogenesis.. Circulation 2007; 115: 2471-2473.
• 25 Sprague AH, Khalil RA. Inflammatory cytokines in vascular dysfunction and vascular disease.. Biochem Pharmacol 2009; 78: 539-552.
• 26 Sayer GL, Smith PD. Immunocytochemical characterisation of the inflammatory cell infiltrate of varicose veins.. Eur J Vasc Endovasc Surg 2004; 28: 479-483.
• 27 Boisseau MR. Leukocyte involvement in the signs and symptoms of chronic venous disease.. Perspectives for therapy. Clin Hemorheol Microcirc 2007; 37: 277-290.
• 28 Michiels C, Arnould T, Janssens D. et al. Interactions between endothelial cells and smooth muscle cells after their activation by hypoxia.. A possible etiology for venous disease. Int Angiol 1996; 15: 124-130.
• 29 Ghaderian SM, Lindsey NJ, Graham AM. et al. Pathogenic mechanisms in varicose vein disease: The role of hypoxia and inflammation.. Pathology 2010; 42: 446-453.
• 30 Sansilvestri-Morel P, Rupin A, Jaisson S. et al. Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells.. Circulation 2002; 106: 479-483.
• 31 Lim CS, Davies AH. Pathogenesis of primary varicose veins.. Br J Surg 2009; 96: 1231-1242.
• 32 Alexander CJ. The theoretical basis of varicose vein formation.. Med J Aust 1972; 1: 258-261.
• 33 Labropoulos N, Giannoukas AD, Delis K. et al. Where does venous reflux start?. J Vasc Surg 1997; 26: 736-742.
• 34 Raffetto JD, Khalil RA. Mechanisms of varicose vein formation: Valve dysfunction and wall dilation.. Phlebology 2008; 23: 85-98.
• 35 Halloran BG, Baxter BT. Pathogenesis of aneurysms.. Semin Vasc Surg 1995; 8: 85-92.
• 36 Libby P. Changing concepts of atherogenesis.. J Intern Med 2000; 247: 349-358.
• 37 Venturi M, Bonavina L, Annoni F. et al. Biochemical assay of collagen and elastin in the normal and varicose vein wall.. J Surg 1996; 60: 245-248.
• 38 Elsharawy MA, Naim MM, Abdelmaguid EM. et al. Role of saphenous vein wall in the pathogenesis of primary varicose veins.. Interact Cardiovasc Thorac Surg 2007; 6: 219-224.
• 39 Sukhova GK, Shi GP, Simon DI. et al. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.. J Clin Invest 1998; 102: 576-583.
• 40 Cheng XW, Kuzuya M, Sasaki T. et al. Increased expression of elastolytic cysteine proteases, cathepsins s and k, in the neointima of balloon-injured rat carotid arteries.. Am J Pathol 2004; 164: 243-251.
• 41 Cheng XW, Obata K, Kuzuya M. et al. Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure.. Hypertension 2006; 48: 979-987.
• 42 Qin Y, Cao X, Guo J. et al. Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.. Cardiovasc Res 2012; 96: 401-410.
• 43 Sun J, Sukhova GK, Zhang J. et al. Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice.. Arterioscler Thromb Vasc Biol 2011; 31: 2500-2508.
• 44 Sun J, Sukhova GK, Zhang J. et al. Cathepsin K deficiency reduces elastase per-fusion-induced abdominal aortic aneurysms in mice.. Arterioscler Thromb Vasc Biol 2012; 32: 15-23.
• 45 Sun J, Zhang J, Lindholt JS. et al. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation.. Circulation 2009; 120: 973-982.
• 46 Pascual G, Mendieta C, Garcia-Honduvilla N. et al. TGF-beta1 upregulation in the aging varicose vein.. J Vasc Res 2007; 44: 192-201.
• 47 Huttunen M, Harvima IT. Mast cell tryptase and chymase in chronic leg ulcers: Chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.. Br J Dermatol 2005; 152: 1149-1160.
• 48 Saarinen J, Kalkkinen N, Welgus HG. et al. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase.. J Biol Chem 1994; 269: 18134-18140.
• 49 Tchougounova E, Forsberg E, Angelborg G. et al. Altered processing of fibronectin in mice lacking heparin.. A role for heparin-dependent mast cell chymase in fibronectin degradation. J Biol Chem 2001; 276: 3772-3777.
• 50 Keski-Oja J, Lohi J, Tuuttila A. et al. Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator.. Exp Cell Res 1992; 202: 471-476.
• 51 Zhang J, Sun J, Lindholt JS. et al. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation.. Circ Res 2011; 108: 1316-1327.
• 52 Johnson JL, Jackson CL, Angelini GD. et al. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques.. Arterioscler Thromb Vasc Biol 1998; 18: 1707-1715.
• 53 Saunders WB, Bayless KJ, Davis GE. MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices.. J Cell Sci 2005; 118: 2325-2340.
• 54 Zhang J, Alcaide P, Liu L. et al. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils.. PLoS One 2011; 6: e14525.
• 55 Naoum JJ, Hunter GC, Woodside KJ. et al. Current advances in the pathogenesis of varicose veins.. J Surg Res 2007; 141: 311-316.
• 56 Qin Y, Shi GP. Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases.. Pharmacol Ther 2011; 131: 338-350.